(Formerly known as Central Clinical School)
5 Aug 2016
Recent CCS publications: Week ending 5 Aug 2016
 |
| Dr Rosie Worsley is one of the authors on the Raloxifene therapy for schizophrenia study |
Abbott IJ, Jenney AW, Spelman DW, Pilcher DV, Sidjabat HE, Richardson LJ, Paterson DL, Peleg AY. Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit. Pathology. 2015 Oct;47(6):575-9. doi: 10.1097/PAT.0000000000000302
Beth SA, Jansen MA, Elfrink ME, Kiefte-de Jong JC, Wolvius EB, Jaddoe VW, van Zelm MC, Moll HA. Generation R birth cohort study shows that specific enamel defects were not associated with elevated serum transglutaminase type 2 antibodies. Acta Paediatr. 2016 Jul 21. doi: 10.1111/apa.13533. [Epub ahead of print]
Blood clot study points to new drug target
 |
| Shauna French and Dr Justin Hamilton analysing results |
Arterial thrombosis – blood clot in an artery – can lead to several serious conditions including heart attack and stroke, and is the most common cause of death and disability in Australia. A Monash PhD student at the Australian Centre for Blood Diseases (ACBD) has conducted research demonstrating a potential new solution to the clotting that causes the problem.
Existing drugs aiming to prevent arterial thrombosis by acting on the platelets that form blood clots have limitations in efficacy and/or safety, some causing excessive bleeding.
Asthma - not a respiratory disease?
 |
| Professor Bruce Thompson, Head of Physiology Services at The Alfred, is trialling a new approach for asthma. |
The Alfred’s Head of Physiology Services Professor Bruce Thompson will trial a new approach by treating asthma not as a respiratory disease, but as a rash. Part of the Centre for Research Excellence on Asthma, a national effort involving investigators around the country, Prof Thompson said the approach is to think differently.
“We’ll be using a commonly used antibiotic that has an anti-inflammatory property. We’ve nebulised the drug so it can be inhaled. No one has done this before.
Congratulations on RACS awards to Geraldine Ooi and James Lee!
 |
| Mr James Lee |
 |
| Dr Geraldine Ooi |
28 Aug 2016 de Castella Run to Mend Minds: Run, Sponsor, Donate - it all helps!
Funds raised will go towards the mental health research at the Monash Alfred Psychiatry Research Centre (MAPrc).Your efforts will help the team of clinicians, researchers and post graduate students to help mend minds as they conduct a series of high quality clinical research projects under the direct supervision of MAPrc Director, Professor Jayashri Kulkarni.
Perspective: St Vincent’s scandal: what’s the protocol for chemotherapy and are low doses less effective?
Ian Haines posits in his 'The Conversation' essay that there is actually no existing evidence to show that a flat dose of 100mg of carboplatin provides inferior outcomes in chemotherapy.
Reference: theconversation.com/st-vincents-scandal-whats-the-protocol-for-chemotherapy-and-are-low-doses-less-effective-63445
Subscribe to:
Posts (Atom)
